Josep Lluis Melero Ferrer

Cardiólogo Clínico. Unidad de IC. Unidad de hipertensión pulmonar. Hospital General Universitari de València.

[CardioTeca @cardioteca]

🚨 Juan José Amaro @jjamaro nos presenta los resultados de los principales estudios presentados en la #AHA23. Excelente resumen!!

[@ICyFA-SEMI @IcyfaSemi]

🆕Algoritmo de diagnóstico y tratamiento de la IC-FEp!!
✅Aquí se puede descargar
👇🏼👇🏼👇🏼👇🏼👇🏼
https://t.co/oTiLWe4XvH
@Sociedad_SEMI @MedicinaSAM @Diabetes_SEMI @PilarCubo @jopesilver @llanossoler1 @pedropabloce @chemachir

[Alfonso Valle @ValleAlfonso]

⚠️Great review👇

⚠️The cardiovascular effects of novel weight loss therapies

📌 current evidence regarding the CV effects of weight-loss interventions

📌practical guidance in developing and implementing treatment plans

📌maximizing CV benefits and minimizing side effects to improve the overall well-being of people with CV disease

📥@ESC_Journals https://t.co/zDKAqsIF5C @JavedButler1 & cia

[Lorenzo Fácila @mi_cardiologo]

Nuevas guías de endocarditis de la @escardio. Indicaciones de la profilaxis en procedimientos oro-dentales.

[CardioTeca @cardioteca]

🆕📌 Finerenona vs. espironolactona: menos hiperpotasemia, más antiinflamatorio y antifibrótico.

Via @JonathanNefro

📁 https://t.co/EQ5fvEbsvZ

[Alfonso Valle @ValleAlfonso]

Mortality, Outcomes, Costs, and Use of 💊 Following a First
Heart Failure🏥 #EVOLUTION HF
👥 263525 patients
👉28% ☠️ within the first year post-HF🏥
👉Re🏥 were mainly driven by HF (ER: 13.6) and CKD (ER: 4.5)
⏰ 2020 ▶️ 2022:
🔴use of RAASI, SV, BB, and MRA hanged little
🟢Sglt2i ↗️ 2- to 7-fold.
📥 https://t.co/Dqpir9yWT8 #CardioTwitter

[Rafael Bravo Marqués @raffabravo]

HP en diferentes escenarios de IC
#AIC_SEC2023
@dr_melero @AlvarezBarredo

[Mar Martínez Quesada @marquesada]

Inauguración oficial de la CX Reunión de IC. Mucho por aprender en dos días…
#AIC_IC2023 @caravaca_pedro @areciomayoral @Dr_Manito @riesgo_SEC @AEEC_enfcardio @SACardiologia

[Alfonso Valle @ValleAlfonso]

Association of Beta-Blocker Therapy With Cardiovascular Outcomes in Patients With Stable Ischemic Heart Disease
👥 28039 stable CAD without heart failure or a recent myocardial infarction
📌The 5-year BB⤵️8%☠️all cause/HF or AMI🏥
👉AMI🏥⤵️ 13%
👉🚫no differences ☠️all cause/HF or AMI🏥
#CardioTwitter

📥 https://t.co/HdvTVtOOmy

[Lorenzo Fácila @mi_cardiologo]

Nuevo palo a los Fibratos para reducir el riesgo cardiovascular reduciendo los triglicéridos. Por ahí vamos mal!!!! https://t.co/Zm3nslZPoM

[CardioTeca @cardioteca]

🆕📌 Síncope reflejo, vaso-vagal, neuromediado: diagnóstico y tratamiento, excelente revisión Heart.

📁 https://t.co/EKy5B92odG

#CardioTwitter #Cardiologia

[CardioTeca @cardioteca]

🆕📌 Infarto de miocardio con arterias coronarias no obstructivas (MINOCA): todo lo que debes saber.

🔓 https://t.co/MKYugze8m0

#CardioTwitter #Cardiologia

[Alfonso Valle @ValleAlfonso]

📝👥 Phenotype Profiling in #HFpEF
to Guide Therapeutic Decision Making

👉 phenotype-based approach for the treatment of HFpEF

👉efficacy of certain💊 can vary within subgroups of patients with HFpEF

👉I SGT2 ➕ diuretics as foundational therapies for patients with HFpEF

👉interventions are advisable based on sex, BMI, and the presence or absence of T2DM, hypertension, COPD, atrial fibrillation and CAD

📥 https://t.co/nzzBywRH3Y @escardio

[Lorenzo Fácila @mi_cardiologo]

La albuminuria es un marcador clave de daño renal y un factor de riesgo cardiovascular independiente. La Dra @anicebrian y Dra B. Fernandez nos lo explican en este video https://t.co/bqGfYxHVxx #finetalks @BayerEspana

[Alejandro Recio @areciomayoral]

#HeartFailure2023 @escardio @secardiologia @HFA_President As presidente of @ICardiacaSEC , it is an honor and privilege to accept the Heart Failure Awareness Day 2023 granted to the Cardio-RED campaign, Madrid, España, during HFA President’s Dinner. Congratulations!!! 👏🏻👏🏻👏🏻

[Alfonso Valle @ValleAlfonso]

#HFpEF: innovative diagnostic approaches and therapeutic targets

👉 heterogeneous presentation
👉 systematic assessment through cardiopulmonary exercise testing combined with exercise echocardiography (CPETecho)
👉 H2FPEF / HFA-PEFF score
❓ What are the roles for cardiologists/HF specialists/general practitioners?
👉general & specific 💊
📥 https://t.co/9LgQQbeIed #CardioTwitter

[Alfonso Valle @ValleAlfonso]

Worsening of chronic heart failure: definition, epidemiology, management and prevention via @escardio

👉 🏥admission is often necessary but treatment in the emergency service or in out-patient clinics or by primary care physicians has become ↗️ used
👉definition
👉clinical characteristics
👉management
👉prevention of WHF in clinical practice

📥 https://t.co/VxxE6x7aAU

[Javier Torres @JTLLERGO]

⚠️ Vericiguat in Heart failure therapy: the fifth card‼️

@ESC_Journals @secardiologia @SACardiologia @clinica_sec @BayerEspana @SJGreene_md @vbluml @AHajduczok @JasonKatzMD @MKIttlesonMD

https://t.co/2mQnEPlbma

[Lorenzo Fácila @mi_cardiologo]

¿Alguien da mas?Pre-tratamiento con #empagliflozina mejora la reperfusión,reduce el tamaño de IAM,la obstrucción microvascular, aumenta el miocardio salvado, preserva la función sistólica reduce la apoptosis y el estrés oxidativo. https://t.co/h2dYEi2Ilc Congrats @santosgallegoMD

[European Society of Cardiology Journals @ESC_Journals]

IV iron reduces the risk of #HF hospitalisation by 33%. Time to implement iron assessments in all HF patients to reduce #HeartFailure hospitalisations and implement quality of life 👉https://t.co/vtX44EyESd

#EJHF @MarcoMetra @_antocannata #HFA_ESC